Albertsons shares plunge 24% after outlook cut
Albertsons (NYSE:ACI) reported first-quarter fiscal 2026 adjusted EPS of $0.42, missing $0.54 estimates and triggering a sharp share sell-off.
Albertsons (NYSE:ACI) reported first-quarter fiscal 2026 adjusted EPS of $0.42, missing $0.54 estimates and triggering a sharp share sell-off.
Nasdaq (NASDAQ:NDAQ) reported second-quarter net revenue of $1.5 billion, up 15%, as each of its three operating divisions recorded growth.
NVR (NYSE:NVR) reported its second-quarter 2026 financial results, generating $2.33 billion in consolidated revenues, a decline from the $2.60 billion reported in the same period last year.
Norfolk Southern (NYSE:NSC) reported its second-quarter 2026 financial results, generating an all-time quarterly record of $3.5 billion in revenue.
Mobileye Global (NASDAQ:MBLY) reported second-quarter revenue of $508 million as higher system shipments offset lower average selling prices.
Eli Lilly (NYSE:LLY) announced positive topline Phase 3 results for its investigational triple agonist, retatrutide, from the 80-week TRIUMPH-2 and TRIUMPH-3 clinical trials.
Thermo Fisher Scientific (NYSE:TMO) reported second-quarter revenue of $11.99 billion, up 10%, as customer activity strengthened across its markets.
Bread Financial (NYSE:BFH) reported its second-quarter 2026 financial results, generating $993 million in revenue.
Lazard (NYSE:LAZ) reported second-quarter net revenue of $808 million, up 1%, while adjusted net revenue increased 2% to $786 million.
Quest Diagnostics (NYSE:DGX) reported second-quarter revenue of $3.04 billion, up 10.2%, as diagnostic-testing volumes increased across its customer channels.
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas